AML is a heterogeneous disease with regard to leukemia-associated genetic abnormalities, and one of the most common abnormalities is insertions in the NPM1 gene (referred to as NPM1-Ins) [1,5,6]. This evidence concerns the gene NPM1 and acute myeloid leukemia.